To include your compound in the COVID-19 Resource Center, submit it here.
Fujifilm's Fujifilm Corp. subsidiary began an open-label, dose-escalation, U.S. Phase I/IIa trial of oral FF-10501 given twice
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury